Sanford launches clinical trial to destroy tumors
Sanford Health has launched a clinical trial using a genetically-engineered virus that aims to destroy therapy-resistant tumors.
Sanford Health has launched a clinical trial using a genetically-engineered virus that aims to destroy therapy-resistant tumors.